23 completed, 4 unknown, 2 withdrawn, 1 not yet recruiting. 32 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 32 | Completed 23, Unknown 4, Withdrawn 2, Not yet recruiting 1, Recruiting 1, Terminated 1 |
| Phase 2 | 3 | Completed 2, Unknown 1 |
Follow Deep Vein Thrombosis: new trials by email Literature Review of Deep Vein Thrombosis trials Research Report on Deep Vein Thrombosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing Rivaroxaban 10 MG, Low Heparin Molecular Weight - Venous Thromboembolism, Deep Vein Thrombosis | Phase 3 | Recruiting | University Hospital, Angers | 1424 | 2024-07-19 | 2026-06-25 |
| The API-CALF Study: Apixaban to Treat Calf Vein Thrombosis Apixaban 2.5 MG Oral Tablet [ELIQUIS] - Deep Vein Thrombosis | Phase 3 | Not yet recruiting | University Hospital, Geneva | 1300 | 2022-09-01 | 2021-07-29 |
| Resolution Enhancement by a Supplemental Obstruction Lessening Venoactive Drug for Eight Weeks in Deep Vein Thrombosis Hydroxyethylrutoside - Deep Vein Thrombosis | Phase 3 | Completed | Maastricht University Medical Center | 44 | 2020-12-08 | 2024-03-01 |
| Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis Apixaban, Enoxaparin - Deep Vein Thrombosis, Malignancy | Phase 3 | Unknown | Beni-Suef University | 100 | 2019-07-03 | 2020-07-08 |
| Generation of Thrombin and Prediction of Deep Vein Thrombosis Post Prosthetic Orthopedic Surgery of the Lower Limbs Blood test, Doppler ultrasound - Deep Vein Thrombosis, Total Hip Prosthesis | Phase 3 | Completed | Centre Hospitalier Universitaire de Nīmes | 146 | 2019-02-21 | 2026-02-11 |
| Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial Recombinant tissue plasminogen activator (rt-PA), Standard Anticoagulation Therapy - Deep Vein Thrombosis, Post-Thrombotic Syndrome | Phase 3 | Withdrawn | University of Colorado, Denver | 2018-07-01 | 2018-08-10 | |
| A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism Dabigatran etexilate, Tinzaparin - Venous Thromboembolism, Deep Vein Thrombosis | Phase 3 | Unknown | The University of Hong Kong | 99 | 2017-09-01 | 2019-04-17 |
| Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy Apixaban - Cerebral Vein Thrombosis, Deep Vein Thrombosis | Phase 3 | Completed | Academic and Community Cancer Research United | 370 | 2017-07-14 | 2025-05-18 |
| Rivaroxaban for the Treatment of Symptomatic Isolated Distal Deep Vein Thrombosis rivaroxaban, Placebo - Deep Vein Thrombosis | Phase 3 | Unknown | Walter Ageno | 1100 | 2017-01-01 | 2018-11-27 |
| Study the Result of Ayurvedic SUVED & Reimmugen (Colostrum) Treatment on Vascular Disease, CAD, CVA, DVT. SUVED, REIMMUGEN, Grain flour placebo - Coronary Artery Disease, Cerebro Vascular Disease | Phase 3 | Completed | Sujata Vaidya | 96 | 2016-01-01 | 2017-09-26 |
| Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism Apixaban, Dalteparin, Questionnaire Administration - Cerebral Vein Thrombosis, Deep Vein Thrombosis | Phase 3 | Completed | Academic and Community Cancer Research United | 300 | 2015-11-20 | 2020-08-04 |
| Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis. Xarelto - Deep Vein Thrombosis, Chronic Portal Vein Thrombosis | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 112 | 2015-09-01 | 2022-07-26 |
| A Safety and Efficacy Study of BCD-080 Compared to Clexan for Deep Vein Thrombosis Prophylaxis at Orthopedic Surgeries Sodium Enoxaparine - Deep Vein Thrombosis | Phase 3 | Completed | Biocad | 124 | 2015-01-01 | 2016-10-24 |
| Prolongation of the Interval Between Prothrombin Time Tests in Stable Patients II Prolonged interval between PT testing - Atrial Fibrillation, Valvular Heart Disease | Phase 3 | Withdrawn | McMaster University | 2014-04-01 | 2014-03-20 | |
| Efficacy of Bemiparin Versus Enoxaparin in the Treatment of DVT Bemiparin sodium, Enoxaparin sodium - Deep Vein Thrombosis | Phase 3 | Completed | Berlin-Chemie AG Menarini Group | 312 | 2013-06-01 | 2016-02-04 |
| AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients Apixaban, Unfractionated Heparin (UFH), Warfarin - Deep Vein Thrombosis, Pulmonary Embolism | Phase 3 | Completed | Pfizer | 80 | 2013-01-01 | 2016-06-23 |
| Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients Rivaroxaban (Xarelto, BAY59-7939), Unfractionated heparin, Warfarin - Deep Vein Thrombosis | Phase 3 | Completed | Bayer | 60 | 2012-03-01 | 2017-01-18 |
| Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis Recombinant tissue plasminogen activator (rt-PA) - Deep Vein Thrombosis, Venous Thrombosis | Phase 3 | Completed | Washington University School of Medicine | 692 | 2009-11-01 | 2018-03-29 |
| Prophylaxis of Thromboembolic Complications Trial: Thromboprophylaxis Needed in Below Knee Plaster Cast Immobilization for Ankle and Foot Fractures Nadroparin, Fondaparinux - Deep Vein Thrombosis, Pulmonary Embolism | Phase 2 / Phase 3 | Unknown | Red Cross Hospital Beverwijk | 669 | 2009-04-01 | 2012-12-18 |
| Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery Enoxaparin, Apixaban, Enoxaparin-matching placebo - Deep Vein Thrombosis, Pulmonary Embolism | Phase 3 | Completed | Bristol-Myers Squibb | 3221 | 2007-06-01 | 2014-07-09 |
Showing 20 of 32. Sign in to see all of them.
Venous Thrombosis (32) · Pulmonary Embolism (14) · Venous Thromboembolism (6) · Postthrombotic Syndrome (3) · Thrombosis (3) · Hemorrhage (2) · Intracranial Thrombosis (2) · Neoplasm Metastasis (2) · Neoplasms (2) · Peripheral Arterial Disease (2) · Ankle Fractures (1) · Atrial Fibrillation (1) · Coronary Artery Disease (1) · Emergencies (1) · Heart Valve Diseases (1)
Cardiovascular Diseases (32) · Embolism and Thrombosis (32) · Vascular Diseases (31) · Thrombosis (29) · Embolism (14) · Lung Diseases (14) · Respiratory Tract Diseases (14) · Thromboembolism (7) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Peripheral Vascular Diseases (3) · Venous Insufficiency (3) · Arterial Occlusive Diseases (2) · Arteriosclerosis (2) · Atherosclerosis (2)
apixaban (8) · Enoxaparin (5) · Rivaroxaban (4) · Dalteparin (3) · Heparin (3) · Heparin, Low-Molecular-Weight (2) · Tinzaparin (2) · Tissue Plasminogen Activator (2) · Warfarin (2) · idraparinux (2) · Dabigatran (1) · Fondaparinux (1) · Hematologic Tests (1) · Hydroxyethylrutoside (1) · Injections (1)
Bristol-Myers Squibb (3) · McMaster University (3) · Academic and Community Cancer Research United (2) · Hamilton Health Sciences Corporation (2) · Sanofi (2) · University of Padova (2) · Assistance Publique - Hôpitaux de Paris (1) · Bayer (1) · Beni-Suef University (1) · Berlin-Chemie AG Menarini Group (1) · Biocad (1) · Centre Hospitalier Universitaire de Nīmes (1) · JIANG Qing (1) · Maastricht University Medical Center (1) · Ottawa Hospital Research Institute (1)
Canada (9) · United States (7) · France (6) · Italy (6) · Russia (5) · Denmark (4) · Poland (4) · Sweden (4) · Australia (3) · Belgium (3) · Brazil (3) · China (3) · Germany (3) · Hungary (3) · India (3)
Jim Julian, MMath (2) · Paolo Prandoni, MD, PhD (2) · Alexander Sitnik, MD, PhD (1) · Ashot Agahanyan, MD (1) · Clive Kearon, MB (1) · Clive Kearon, MB Ph.D (1) · Clive Kearon, MB, MRCP, FRCP(C), PhD (1) · Clive Kearon, MD (1) · Delphine Douillet, Doctor (1) · Dr Shreepad M Bhat, MD (1)
PMID 35570249, PMID 23279103, PMID 26867832, PMID 31630479, PMID 10737280, PMID 10963635, PMID 12393647, PMID 15809460, PMID 16458642, PMID 16926353, PMID 17635708, PMID 17635709, PMID 17855670, PMID 17855671, PMID 18664970, PMID 18840838, PMID 19078910, PMID 19348685, PMID 19414836, PMID 19657123, PMID 19718469, PMID 19817986, PMID 20047905, PMID 20124539, PMID 20206776, PMID 20694281, PMID 20860504, PMID 20971330, PMID 20971331, PMID 21175312, PMID 21832920, PMID 22032881, PMID 22082302, PMID 22180438, PMID 22315267, PMID 22449293, PMID 22898071, PMID 23318311, PMID 23425163, PMID 23537968, PMID 23702623, PMID 23725876, PMID 23808982, PMID 23991658, PMID 24472834, PMID 25717286, PMID 25851062, PMID 26332772, PMID 26407753, PMID 27836513
2015 (1), 2016 (1), 2023 (1), P30CA015083 (1), U01HL088476 (1)